1.
Wu Y, Liu H, Gong Y, Zhang B, Chen W. ANKRD22 enhances breast cancer cell malignancy by activating the Wnt/β-catenin pathway via modulating NuSAP1 expression. Bosn J of Basic Med Sci [Internet]. 2021Jun.1 [cited 2021May16];21(3):294-0. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/4701